AHG (Akso Health Group ADS)
Insider Trading Activity
Every open-market purchase and sale reported by AHG officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2008-09-08 | William E Monast | Exec. Vice President, Sales | MIXED | — | — |
| 2008-08-14 | William E Monast | Exec. Vice President, Sales | MIXED | — | — |
| 2008-07-02 | LAWRENCE A MASTROVICH | President and COO | MIXED | — | — |
| 2008-06-06 | RICHARD KOPPES | Director | MIXED | — | — |
| 2008-06-02 | DAVID L GOLDSMITH | Director | M | — | — |
| 2008-04-09 | DANIEL E GREENLEAF | President, Coram Infusion Div. | A | — | — |
| 2008-03-04 | CHRIS A. KARKENNY | Executive VP & CFO | A | — | — |
| 2008-03-04 | LAWRENCE A MASTROVICH | President & COO | A | — | — |
| 2008-03-04 | LAWRENCE M HIGBY | Chief Executive Officer | A | — | — |
| 2008-03-04 | William E Monast | Executive VP, Sales | A | — | — |
| 2008-02-20 | CHRIS A. KARKENNY | Executive VP & CFO | MIXED | — | — |
| 2008-02-20 | William E Monast | Executive VP, Sales | MIXED | — | — |
| 2008-02-20 | LAWRENCE M HIGBY | Chief Executive Officer | MIXED | — | — |
| 2008-02-20 | LAWRENCE A MASTROVICH | President & COO | MIXED | — | — |
| 2008-01-03 | LAWRENCE M HIGBY | Chief Executive Officer | MIXED | — | — |
| 2008-01-03 | LAWRENCE A MASTROVICH | President & COO | MIXED | — | — |
| 2007-12-03 | DAVID L GOLDSMITH | Director | MIXED | — | — |
| 2007-11-21 | CHRIS A. KARKENNY | Executive V. President & CFO | MIXED | — | — |
| 2007-09-06 | William Jeffrey Ingram | EVP, Sales | F | — | — |
| 2007-09-06 | William J Monast | EVP, Sales | A | — | — |
| 2007-07-03 | LAWRENCE A MASTROVICH | President and COO | MIXED | — | — |
| 2007-05-07 | I T CORLEY | Director | A | — | — |
| 2007-05-07 | VICENTE ANIDO JR | Director | A | — | — |
| 2007-05-07 | TERRY BAYER | Director | A | — | — |
| 2007-05-07 | RICHARD KOPPES | Director | A | — | — |
| 2007-05-07 | MAHVASH YAZDI | Director | A | — | — |
| 2007-05-07 | PHILIP R LOCHNER | Director | A | — | — |
| 2007-05-07 | DAVID L GOLDSMITH | Director | A | — | — |
| 2007-05-07 | NORMAN C MD PAYSON | Director | A | — | — |
| 2007-04-18 | LAWRENCE A MASTROVICH | President and C.O.O. | MIXED | — | — |
| 2007-04-05 | LAWRENCE A MASTROVICH | President and C.O.O. | MIXED | — | — |
| 2007-03-09 | LAWRENCE M HIGBY | Chief Executive Officer | A | — | — |
| 2007-03-09 | William Jeffrey Ingram | EVP, Sales | A | — | — |
| 2007-03-09 | CHRIS A. KARKENNY | EVP and CFO | A | — | — |
| 2007-03-09 | LAWRENCE A MASTROVICH | President and COO | A | — | — |
| 2007-03-09 | William Jeffrey Ingram | EVP, Sales | MIXED | — | — |
| 2007-03-09 | LAWRENCE M HIGBY | Chief Executive Officer | MIXED | — | — |
| 2007-03-07 | LAWRENCE M HIGBY | Chief Executive Officer | MIXED | — | — |
| 2007-02-28 | PHILIP R LOCHNER | Director | MIXED | — | — |
| 2007-02-23 | LAWRENCE A MASTROVICH | President and COO | MIXED | — | — |
| 2007-02-21 | CHRIS A. KARKENNY | Executive Vice President & CFO | A | — | — |
| 2007-02-21 | William Jeffrey Ingram | EVP, Sales | A | — | — |
| 2007-02-21 | LAWRENCE A MASTROVICH | President and COO | MIXED | — | — |
| 2007-02-21 | LAWRENCE M HIGBY | Chief Executive Officer | MIXED | — | — |
| 2007-02-20 | LAWRENCE M HIGBY | Chief Executive Officer | M | — | — |
| 2007-02-20 | William Jeffrey Ingram | EVP, Sales | M | — | — |
| 2007-02-20 | LAWRENCE A MASTROVICH | President and COO | M | — | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AHG quote page; the site-wide leaderboard is on the insider transactions hub.